The CEO of pharmaceutical company AstraZeneca has said his company’s coronavirus vaccine candidate could be ready for use by the end of December, pending regulatory approval.
–
“Regulatory authorities work with our data all the time. If they act quickly when our vaccine is ready, we can start vaccinating people in January, maybe even by the end of December, ”said Pascal Soriot, the company’s CEO, according to the Swedish newspaper Today’s News Saturday.
The Anglo-Swedish drug company is teaming up with Oxford University in Great Britain to create a candidate vaccine for the coronavirus, considered one of the most promising in the race to find a corona vaccine.
Soriot said many experts believe that revaccinations should be performed, perhaps annually. “But we have to make sure the vaccine really works,” he said.
The vaccine entered its third phase of testing in September. This phase was temporarily interrupted due to health problems in a patient taking part in testing in Great Britain, but has since resumed.
The European Union, the United States, the United Kingdom, Japan and Brazil have signed initial contracts with AstraZeneca for the supply of vaccines, once approved.
– .
